Self-Promoting
On October 6th I told readers to look into Johnson & Johnson (JNJ). Today JNJ hit another 52-week high. Readers could have made a quick 4.7%. For the risk averse, Nabi Biopharma (NABI) is up 14% since I mentioned it and NeoPharm (NEOL) is up a HEFTY 41%. Nice work Big Ben! I wish I had followed my own advice.
posted by Big Ben at Wednesday, October 18, 2006
1 Comments:
Especially NEOL. Although after doing some more research on NEOL; the company has cut R&D and put all of its eggs into one drug. NEOL still has some nice insider buying.
Post a Comment
<< Home